TF is a major regulator of coagulation and hemostasis.
Introduction
Endothelial cells modulate several aspects of the hemostasis-coagulation sequence, and possess antiplatelet, anticoagulant, and fibrinolytic properties (1). On the other hand, when they are injured or activated, they may exert procoagulant functions.
Thrombosis is considered to occur when the balance between thrombotic factors and endothelial protective mechanisms is broken out.
The thrombogenic factors are as follows ; 1) perturbation of endothelial cells, 2) loss of endothelial cells with exposure of subendothelium, 3) activation of platelets by their interaction with subendothelial collagen or circulating agonists, 4) activation of blood coagulation, 5) inhibition of fibrinolysis, and 6) stasis.
In these factors, however, loss of endothelial cells is essential in thrombogenesis in the arteries, while the activation of blood coagulation mainly due to deficiency of coagulation inhibitors is considered to be an important factor in the microcirculation.
Tissue factor (TF) initiates the extrinsic coagulation cascade and is a major regulator of coagulation, hemostasis, and thrombosis.
TF is a 47-kD transmembrane glycoprotein and a specific cofactor for plasma coagulation factor VII/V11a. Although native TF itself has no intrinsic protease activity, the bimolecular complex of TF and factor VII/VIla results in catalytic enhancement of the factor Vila catalytic domain and activates factors IX and X thereby leading to thrombin generation (2, 3). In normal vessels, TF is present only in the adventitia (4, 5) . Recent studies show that TF is overexpressed in atherosclerotic lesions and contributes to the plaque thrombogenicity (6-11).
We examined the role of TF in thrombogenicity of the atherosclerotic lesions of human and an animal model, and in the endotoxin-induced DIC model.
TF in Human Atherosclerotic Lesions
The critical event converting asymptomatic atherosclerotic lesions into symptomatic ones is considered to be thrombosis.
Plaque rupture or fissure is the most fre-Asada et al.
quent cause of coronary thrombosis and in the clinical presentation of acute coronary syndromes (12, 13). Fibrin-rich large thrombi were very frequently observed on and in the ruptured plaques (Fig. 1) . Atherosclerotic plaques that are vulnerable to rupture have a dense infiltrate of macrophages and, to a lesser extent, lymphocytes within a fibrous cap overlying a crescentic acellular mass of lipids (13). Plaque erosion has recently been identified as the another mechanism of coronary thrombosis, and is an important cause of sudden coronary death (14). In contrast with ruptured plaques, eroded plaques are rich in smooth muscle cells (SMCs) and proteoglycans and are lacking a superficial lipid core (Fig.  2) . Although plaque rupture is more common than plaque erosion as a cause of major thrombi, it has been reported that, in an autopsy study of sudden cardiac death, culprit thrombi were frequently (>40%) found on eroded plaques (14). Additionally, in women who died suddenly of ischemic heart disease, 69% of the thrombi were due to plaque erosion (14) .
High levels of TF antigen, mRNA, and activity have been detected in atherosclerotic plaques obtained by human atherectomy of the carotid and coronary arteries (6, 7). Additionally it has been recently reported that higher levels of TF antigen were observed in coronary atherectomy specimens from patients with unstable angina than with stable angina (8). The immunohistochemical studies revealed that TF antigen was present in macrophages, SMCs, and the extracellular matrix, most intensely in cholesterol crystal-rich areas of the plaques (6, 7).
In our study (11), TF antigen was detected in the various stages of atherosclerotic lesions (diffuse intimal thickening, fatty streak, and atheromatous plaque).
In diffuse intimal thickening, almost all of the intimal SMCs were positive for TF. In fatty streaks, many foamy macrophages were positively stained for TF (Fig. 3) . In atheromatous plaques, TF antigen was extensively observed extracellularly as well as in the intimal cells. TF-positive cells were mainly SMCs in the fibrous cap and were macrophages in the shoulder areas of the plaques. Additionally TF activity was detected by a chromogenic assay using S-2222, and was higher in the fatty streaks and the atheromatous plaques than in the diffuse intimal thickening.
These results indicate that TF detected immunohistochemically in the lesions is biologically active. Prominent TF expression in the advanced lesions is considered to contribute to thrombus formation on plaque rupture. In addtion, exposing active TF of intimal SMCs to circulating blood could become the trigger of acute thrombosis on plaque erosion.
On the other hand, a monolayer or small aggregates of platelets without fibrin were occasionally observed on the de-endothelialized areas of the fibrous cap. These areas Plaque rupture (asterisk) with an occlusive thrombus is present.
The plaque contains a large lipid core and dense infiltrate of foamy macrophages is noted in the were rich in collagen bundles but lacking cellular elements or superficial lipid core (Fig. 4) . The evidence suggests that the exposure of cellular and extracellular TF to circulating blood is of great significance for thrombin generation and fibrin-rich thrombus formation on the plaques.
Thrombus Formation on the Neointima in Animal Models
Thrombus formation is commonly associated with acute arterial injury. Fibrin generation and thrombus formation on the injured vessel are natural consequences after balloon angioplasty, directional atherectomy, or arterial stenting.
Therefore, the study of responses of diseased vessels to injury is relevant to the thrombus formation and restenosis after angioplasty in the clinical setting.
It is well known that superficial injury (endothelial denudation without medial injury) of normal arteries is associated with platelet adhesion on the subendothelium without fibrin generation (15), while several reports showed that fibrin deposition was induced on the injured neointima (16-18). We examined thrombus formation following the second balloon injury to the rabbit aorta injured 4 weeks earlier (19). The neointima 4 weeks after the first balloon injury was composed exclusively of SMCs and almost all of these SMCs were immunohistochemically positive for TF antigen.
This finding is similar to that of human diffuse intimal thickening.
In this study, two kinds of thrombus (platelet-rich and fibrin-rich) were induced on the injured surface of the rabbit neointima.
Platelet-rich thrombi were formed on the mildly injured neointima, in which the connective tissue was mainly exposed without intimal SMC damage, whereas fibrin-rich large thrombi were formed on the severely injured neointima associated with obvious damage of intimal SMCs. This evidence indicates that the exposure of TF derived from the damaged intimal SMCs may contribute to the initiation of the coagulation pathway, leading to the thrombin generation and fibrin formation (Fig. 5) .
Thrombi have long been implicated in the formation of the neointima.
Much of the neointimal volume appears to be related to the early fibrin-rich mural thrombi, and fibrin thrombi were found to be important in restenosis because they provided volume into which SMC migrated and for SMC proliferation (20, 21) . Fibrin and fibrin fragments are chemotactic for SMCs in vitro (22), and thrombin has been shown to activate platelets and stimulate SMC proliferation (23). In addition, we have recently demonstrated that the migration of the cultured aortic SMCs was induced by a complex of TF-factor Vila (24). Therefore, TF seems to affect the neointimal development through direct or indirect action on SMCs. These findings support the possibility that TF in the intima plays an important role in the development and progression of atherosclerosis as well as in thrombus formation.
TF in LPS-induced DIC Model
Disseminated intravascular coagulation (DIC) is a frequent complication of endotoxin shock, and modulation of endothelial cell hemostatic properties has been proposed to play an important role in its onset. The trigger mechanisms of DIC in sepsis are not fully understood but endotoxin is considered to play an important role in them (25, 26) . In recent clinical studies, a significant role of plasma TF has been suggested in the pathogenesis of DIC (26-28), and high levels of plasma TF activity in DIC rats have also been reported (29). The origin of plasma TF increased in DIC patients remains to be clarified. Possible cells are monocytes and endothelial cells. TF is not normally present in these cells, but on stimulation with a variety of inflammatory agents such as lipopolysaccharide Fig. 4 (LPS), interleukin-1, and tumor necrosis factor-a, these cells can synthesize and express TF on their surfaces in the culture system (3). However, whether endothelial cells can express TF in vivo remains controversial. Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that directly inhibits factor Xa and produces a feedback inhibition of the TF-factor Vila catalytic complex in a factor Xa-dependent manner (30). TFPI is considered to be one of the most important physiological inhibitors in vivo among the known inhibitors of TF-dependent coagulation.
It has been reported that TFPI was present on the surface of microvascular endothelial cells and in megakaryocytes (31). Recently a few clinical studies examined the plasma TFPI level in DIC patients, but the relationship with the prognosis of DIC is still unclear (32, 33). On the other hand, the role of TFPI against endotoxin-induced DIC has been emphasized in the several studies using DIC animal models (34-37).
We examined the expression of TF and TFPI in rat lungs of a LPS-induced DIC model (38). Light and electron microscopic studies showed that fibrin-rich thrombi were present in the pulmonary microvasculature 3 hours after intraperitoneal injection of LPS (7.5 mg/kg) and increased in number at 6 hours. Monocytes in the microvasculature increased in number following LPS injection and many of these cells (> 90%) were immunohistochemically positive for TF antigen.
However, no TF expression in endothelial cells was detected.
Pulmonary endothelial cells showed positive reaction for TFPI antigen before LPS injection, but TFPI-positive endothelial cells markedly decreased in number after LPS injection. mRNA expression of TF increased and that of TFPI decreased in the lung tissue after LPS injection. High values of TF activity were detected in the lung tissue and plasma, whereas TFPI activities decreased after LPS injection.
The results of previous and the present studies indicate that the imbalance between TF and TFPI seems to be important in promoting fibrin thrombus formation in the lung under a certain condition such as a fulminant endotoxin influx into the blood circulation. 
